Risk-benefit assessment of ivabradine in the treatment of chronic heart failure

Urbanek I, Kaczmarek K, Cygankiewicz I, Ptaszynski P

Drug, Healthcare and Patient Safety 2014, 6:47-54

Published Date: 28 April 2014